Prof. Marco Rastrelli is a medical director, associate professor, and head of the Sarcoma Unit at the Veneto Institute of Oncology IOV-IRCCS. He graduated in Medicine and Surgery. He specialized in General Surgery at the University of Padua. He has served as a surgical oncologist at the Oncologic Endocrine Surgery, Hammersmith Hospital, Oncologic Abdominal Surgery, Ealing Hospital, and Division of Melanoma and Sarcoma Surgery, European Institute of Oncology. He mainly deals with research and treatment in the field of soft tissue sarcomas of the limbs and retroperitoneum, desmoid fibromatosis, and gastrointestinal stromal tumors (GIST). His further areas of interest include the surgery of melanomas and locoregional therapies of the limb (hyperthermic antiblastic perfusion and infusion) for the treatment of locally advanced neoplasms (sarcomas and melanomas). He is the Principal Investigator of multiple Italian and international controlled clinical studies on soft tissue sarcomas (limb and retroperitoneum) and melanomas in compliance with GCP. He is a member of the Italian Sarcoma Group (ISG), Soft Tissue and Bone Sarcoma Group (EORTC), Transatlantic Group (TARPSWG) for the study of retroperitoneal sarcomas, and Sarcoma Group of the Italian Society of Oncological Surgery (SICO). He is the author of numerous publications in international medical journals.
Prof. Marco Rastrelli is a medical director, associate professor, and head of the Sarcoma Unit at the Veneto Institute of Oncology IOV-IRCCS. He graduated in Medicine and Surgery. He specialized in General Surgery at the University of Padua. He has served as a surgical oncologist at the Oncologic Endocrine Surgery, Hammersmith Hospital, Oncologic Abdominal Surgery, Ealing Hospital, and Division of Melanoma and Sarcoma Surgery, European Institute of Oncology. He mainly deals with research and treatment in the field of soft tissue sarcomas of the limbs and retroperitoneum, desmoid fibromatosis, and gastrointestinal stromal tumors (GIST). His further areas of interest include the surgery of melanomas and locoregional therapies of the limb (hyperthermic antiblastic perfusion and infusion) for the treatment of locally advanced neoplasms (sarcomas and melanomas). He is the Principal Investigator of multiple Italian and international controlled clinical studies on soft tissue sarcomas (limb and retroperitoneum) and melanomas in compliance with GCP. He is a member of the Italian Sarcoma Group (ISG), Soft Tissue and Bone Sarcoma Group (EORTC), Transatlantic Group (TARPSWG) for the study of retroperitoneal sarcomas, and Sarcoma Group of the Italian Society of Oncological Surgery (SICO). He is the author of numerous publications in international medical journals.